Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells

Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells

The molecular mechanisms of reduced frataxin (FXN) expression in Friedreich's ataxia (FRDA) are linked to epigenetic modification of the FXN locus caused by the disease-associated GAA expansion. Here, we identify that SUV4-20 histone methyltransferases, specifically SUV4-20 H1, play an importan...

Bibliografiset tiedot
Päätekijät:	Vilema Enriquez, MG, Quinlan, R, Kilfeather, P, Mazzone, R, Saqlain, S, Del Molino Del Barrio, I, Donato, A, Corda, G, Li, F, Vedadi, M, Németh, AH, Brennan, PE, Wade-Martins, R
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	American Society for Biochemistry and Molecular Biology 2020

Samankaltaisia teoksia

Epigenetic modification of the frataxin gene for the treatment of Friedreich’s ataxia
Tekijä: Vilema Enriquez, MG
Julkaistu: (2018)

Strategies for increasing frataxin expression in Friedreich's ataxia: modulation of the epigenome and proteome
Tekijä: Quinlan, R
Julkaistu: (2021)

Pharmacological inhibition of the methyltransferases SUV4-20 in cellular models of Friedreich’s ataxia
Tekijä: Maheshwari, S
Julkaistu: (2021)

Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich’s Ataxia Blood
Tekijä: Qingqing Wang, et al.
Julkaistu: (2022-04-01)

DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
Tekijä: Layne N. Rodden, et al.
Julkaistu: (2022-03-01)

Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia.
Tekijä: Heather L Plasterer, et al.
Julkaistu: (2013-01-01)

Novel frataxin isoforms may contribute to the pathological mechanism of Friedreich ataxia.
Tekijä: Haiyan Xia, et al.
Julkaistu: (2012-01-01)

Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain
Tekijä: Davide Doni, et al.
Julkaistu: (2023-12-01)

HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.
Tekijä: Myriam Rai, et al.
Julkaistu: (2008-01-01)

P003: Clinical laboratory experience of frataxin quantification in blood for the diagnosis of Friedreich ataxia*
Tekijä: Iris Pantovich, et al.
Julkaistu: (2024-01-01)

Correction: Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain
Tekijä: Davide Doni, et al.
Julkaistu: (2024-01-01)

Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC‐neurons and cardiomyocytes
Tekijä: Mariana B. Angulo, et al.
Julkaistu: (2023-01-01)

Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.
Tekijä: QingQing Wang, et al.
Julkaistu: (2018-01-01)

Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
Tekijä: Mittal Jasoliya, et al.
Julkaistu: (2019-01-01)

Recent Advances in the Elucidation of Frataxin Biochemical Function Open Novel Perspectives for the Treatment of Friedreich’s Ataxia
Tekijä: Beata Monfort, et al.
Julkaistu: (2022-03-01)

A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins
Tekijä: Pierre Chapdelaine, et al.
Julkaistu: (2013-01-01)

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia
Tekijä: Laura Rodríguez-Pascau, et al.
Julkaistu: (2021-01-01)

Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application
Tekijä: Saumya Maheshwari, et al.
Julkaistu: (2023-09-01)

The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.
Tekijä: Nadège Calmels, et al.
Julkaistu: (2009-07-01)

Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia
Tekijä: Dörte Poburski, et al.
Julkaistu: (2016-05-01)

Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen
Tekijä: Haiech Jacques, et al.
Julkaistu: (2009-08-01)

An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models
Tekijä: Catherine Gérard, et al.
Julkaistu: (2014-01-01)

Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model
Tekijä: Tommaso Vannocci, et al.
Julkaistu: (2018-06-01)

Frataxin gene editing rescues Friedreich’s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons
Tekijä: Pietro Giuseppe Mazzara, et al.
Julkaistu: (2020-08-01)

Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts.
Tekijä: Kevin Kemp, et al.
Julkaistu: (2011-01-01)

Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTag
Tekijä: Khadija Cherif, et al.
Julkaistu: (2018-09-01)

Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
Tekijä: Simonetta Bandiera, et al.
Julkaistu: (2013-01-01)

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
Tekijä: Alessandra Rufini, et al.
Julkaistu: (2015-03-01)

Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model.
Tekijä: Myriam Rai, et al.
Julkaistu: (2010-01-01)

Genetics and Friedreich Ataxia
Tekijä: J Gordon Millichap
Julkaistu: (2002-06-01)

Genetics of Friedreich Ataxia
Tekijä: J Gordon Millichap
Julkaistu: (1997-06-01)

The pathogenesis of cardiomyopathy in Friedreich ataxia.
Tekijä: Arnulf H Koeppen, et al.
Julkaistu: (2015-01-01)

Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia
Tekijä: Daniel Fil, et al.
Julkaistu: (2020-07-01)

Catastrophic visual loss in a patient with Friedreich ataxia.
Tekijä: Porter, N, et al.
Julkaistu: (2007)

Predictors of loss of ambulation in Friedreich's ataxia
Tekijä: Christian Rummey, et al.
Julkaistu: (2020-01-01)

Late-Onset Friedreich’s Ataxia
Tekijä: J Gordon Millichap
Julkaistu: (1993-08-01)

Friedreich’s Ataxia with Retained Reflexes
Tekijä: J Gordon Millichap
Julkaistu: (1995-04-01)

Friedreich's Ataxia and Glucose Metabolism
Tekijä: J Gordon Millichap
Julkaistu: (1988-08-01)

5-Hydroxytryptophan in Friedreich’s Ataxia
Tekijä: J Gordon Millichap
Julkaistu: (1995-06-01)

Iron Storage in Friedreich’s Ataxia
Tekijä: J Gordon Millichap
Julkaistu: (1999-08-01)